** Advanced wound care company's shares ALQA.O up 9.7 pct
at $2.27
** Privately held biopharma co Adynxx enters into deal to
buy ALQA
** Adynxx stockholders will become the majority owners of
Alliqua's outstanding common stock urn:newsml:reuters.com:*:nPn8bl1sJa
** Merger to create a clinical-stage pharma company with
focus on pain and inflammation diseases; Alliqua will be renamed
Adynxx on deal closure
** Alliqua is also exploring alternatives for its hydrogel
manufacturing facility in Pennsylvania
** Stock has risen 24 pct this year
(Reporting by Amy Caren Daniel in Bengaluru)
((Reuters Messaging:
Amy.CarenDaniel.thomsonreuters.com@reuters.net))